<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "3: most significant factors affecting", fill: "#65000b"},
{source: "3: most significant factors affecting", target: "3: operations", fill: "#65000b"},
{source: "3: operations", target: "3: dependent", fill: "#65000b"},
{source: "3: dependent", target: "3: expenditures", fill: "#65000b"},
{source: "3: expenditures", target: "3: pharmaceutical", fill: "#65000b"},
{source: "3: pharmaceutical", target: "3: life sciences industries", fill: "#65000b"},
{source: "3: life sciences industries", target: "3: factors could", fill: "#65000b"},
{source: "3: factors could", target: "3: overall levels", fill: "#65000b"},
{source: "3: most significant factors affecting", target: "4: highly dependent on expenditures by companies", fill: "#00563f"},
{source: "4: highly dependent on expenditures by companies", target: "4: pharmaceutical", fill: "#00563f"},
{source: "4: pharmaceutical", target: "4: sciences industries", fill: "#00563f"},
{source: "4: sciences industries", target: "4: advertising", fill: "#00563f"},
{source: "4: advertising", target: "4: promotional marketing", fill: "#00563f"},
{source: "4: promotional marketing", target: "4: sales recruiting clinical staffing", fill: "#00563f"},
{source: "4: sales recruiting clinical staffing", target: "4: compliance services", fill: "#00563f"},
{source: "4: highly dependent on expenditures by companies", target: "8: Companies ", fill: "#ce2029"},
{source: "8: Companies ", target: "8: advertising promotional marketing sales", fill: "#ce2029"},
{source: "8: advertising promotional marketing sales", target: "8: services internally based on industry", fill: "#ce2029"},
{source: "8: services internally based on industry", target: "8: internally", fill: "#ce2029"},
{source: "8: internally", target: "8: new product development", fill: "#ce2029"},
{source: "8: new product development", target: "8: sales representatives employed", fill: "#ce2029"},
{source: "8: sales representatives employed", target: "8: promote new", fill: "#ce2029"},
{source: "8: promote new", target: "8: competition from", fill: "#ce2029"},
{source: "8: Companies ", target: "11: provide services", fill: "#ff55a3"},
{source: "11: provide services", target: "11: most significant clients under contracts", fill: "#ff55a3"},
{source: "11: most significant clients under contracts", target: "11: clients may cancel on", fill: "#ff55a3"},
{source: "11: provide services", target: "14: cannot assure", fill: "#ffebcd"},
{source: "14: cannot assure", target: "14: most significant clients will continue", fill: "#ffebcd"},
{source: "14: most significant clients will continue", target: "14: with us over", fill: "#ffebcd"},
{source: "14: cannot assure", target: "16: integrating several significant acquisitions", fill: "#ffdab9"},
{source: "16: integrating several significant acquisitions", target: "16: significant", fill: "#ffdab9"},
{source: "16: significant", target: "16: acquisitions", fill: "#ffdab9"},
{source: "16: acquisitions", target: "16: businesses", fill: "#ffdab9"},
{source: "16: businesses", target: "16: complement", fill: "#ffdab9"},
{source: "16: complement", target: "16: strategically", fill: "#ffdab9"},
{source: "16: strategically", target: "16: accretive", fill: "#ffdab9"},
{source: "16: integrating several significant acquisitions", target: "18: current market", fill: "#69c"},
{source: "18: current market", target: "18: acquisition targets", fill: "#69c"},
{source: "18: acquisition targets", target: "18: extremely competitive", fill: "#69c"},
{source: "18: extremely competitive", target: "18: successfully bid", fill: "#69c"},
{source: "18: successfully bid", target: "18: acquisitions necessary", fill: "#69c"},
{source: "18: acquisitions necessary", target: "18: financial goals", fill: "#69c"},
{source: "18: current market", target: "20: Operational ", fill: "#f0ead6"},
{source: "20: Operational ", target: "20: integration", fill: "#f0ead6"},
{source: "20: integration", target: "20: businesses", fill: "#f0ead6"},
{source: "20: businesses", target: "20: difficulties", fill: "#f0ead6"},
{source: "20: Operational ", target: "26: acquisitions", fill: "#92000a"},
{source: "26: acquisitions", target: "26: inherently", fill: "#92000a"},
{source: "26: inherently", target: "26: future acquisitions will", fill: "#92000a"},
{source: "26: future acquisitions will", target: "26: materially", fill: "#92000a"},
{source: "26: materially", target: "26: adversely affect", fill: "#92000a"},
{source: "26: acquisitions", target: "27: Failure ", fill: "#c71585"},
{source: "27: Failure ", target: "27: successfully", fill: "#c71585"},
{source: "27: successfully", target: "27: acquisitions", fill: "#c71585"},
{source: "27: acquisitions", target: "27: consolidated", fill: "#c71585"},
{source: "27: Failure ", target: "28: infrastructure", fill: "#f0dc82"},
{source: "28: infrastructure", target: "28: support continued growth", fill: "#f0dc82"},
{source: "28: infrastructure", target: "33: government regulation", fill: "#702963"},
{source: "33: government regulation", target: "37: evolving industry standards", fill: "#0c9"},
{source: "37: evolving industry standards", target: "37: technological", fill: "#0c9"},
{source: "37: evolving industry standards", target: "START_HERE", fill: "#0c9"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Advertising</td>
    </tr>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Trading Companies and Distributors</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Empathize</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Pharmaceutics">Pharmaceutics</a></td>
      <td>Pharmaceutics is the discipline of pharmacy that deals with the process of turning a new chemical entity (NCE) or old drugs into a medication to be used safely and effectively by patients.  It is also called the science of dosage form design.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Teva_Pharmaceuticals">Teva Pharmaceuticals</a></td>
      <td>Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company with headquarters in Petah Tikva, Israel.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Marketing">Marketing</a></td>
      <td>Marketing is the process of exploring, creating, and delivering value to meet the needs of a target market in terms of goods and services; potentially including selection of a target audience; selection of certain attributes or themes to emphasize in advertising; operation of advertising campaigns; attendance at trade shows and public events; design of products and packaging attractive to buyers; defining the terms of sale, such as price, discounts, warranty, and return policy; product placement in media or with people believed to influence the buying habits of others; agreements with retailers, wholesale distributors, or resellers; and attempts to create awareness of, loyalty to, and positive feelings about a brand. Marketing is typically done by the seller, typically a retailer or manufacturer.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/AIDA_(marketing)">AIDA (marketing)</a></td>
      <td>The AIDA model is just one of a class of models known as hierarchy of effects models or hierarchical models, all of which imply that consumers move through a series of steps or stages when they make purchase decisions. These models are linear, sequential models built on an assumption that consumers move through a series of cognitive (thinking) and affective (feeling) stages culminating in a behavioural (doing e.g.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Company">Company</a></td>
      <td>A company, abbreviated as co., is a legal entity representing an association of people, whether natural, legal or a mixture of both, with a specific objective. Company members share a common purpose and unite to achieve specific, declared goals.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Holding_company">Holding company</a></td>
      <td>A holding company is a company whose primary business is holding a controlling interest in the securities of other companies. A holding company usually does not produce goods or services itself.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Queen_Elisabeth_Competition">Queen Elisabeth Competition</a></td>
      <td>The Queen Elisabeth Competition (Dutch: Koningin Elisabethwedstrijd, French: Concours musical international Reine Élisabeth) is an international competition for career-starting musicians held in Brussels. The competition is named after Queen Elisabeth of Belgium (1876–1965).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/From_Companionship_to_Competition">From Companionship to Competition</a></td>
      <td>From Companionship to Competition is an album by New York City hardcore punk band Kill Your Idols. It was released in January 2005 on SideOneDummy Records.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Perfect_competition">Perfect competition</a></td>
      <td>In economics, specifically general equilibrium theory, a perfect market, also known as an atomistic market, is defined by several idealizing conditions, collectively called perfect competition, or atomistic competition. In theoretical models where conditions of perfect competition hold, it has been demonstrated that a market will reach an equilibrium in which the quantity supplied for every product or service, including labor, equals the quantity demanded at the current price.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Contract">Contract</a></td>
      <td>A contract is a legally enforceable agreement that creates, defines, and governs mutual rights and obligations among its parties. A contract typically involves the transfer of goods, services, money, or a promise to transfer any of those at a future date.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Medical_license">Medical license</a></td>
      <td>A medical license is an occupational license that permits a person to legally practice medicine. In most countries, a person must have a medical license bestowed either by a specified government-approved professional association or a government agency before he or she can practice medicine.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_mergers_and_acquisitions_by_Alphabet">List of mergers and acquisitions by Alphabet</a></td>
      <td>Google is a computer software and a web search engine company that acquired, on average, more than one company per week in 2010 and 2011. The table below is an incomplete list of acquisitions, with each acquisition listed being for the respective company in its entirety, unless otherwise specified.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Library_acquisitions">Library acquisitions</a></td>
      <td>Library acquisitions is the department of a library responsible for the selection and purchase of materials or resources. The department may select vendors, negotiate consortium pricing, arrange for standing orders, and select individual titles or resources.Libraries, both physical and digital, usually have four common broad goals that help dictate these responsibilities.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Mergers_&amp;_Acquisitions">Mergers &amp; Acquisitions</a></td>
      <td>In corporate finance, mergers and acquisitions (M&amp;A) are transactions in which the ownership of companies, other business organizations, or their operating units are transferred or consolidated with other entities. As an aspect of strategic management, M&amp;A can allow enterprises to grow or downsize, and change the nature of their business or competitive position.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_Is_Business">Business Is Business</a></td>
      <td>Business-to-business (B2B or, in some countries, BtoB) is a situation where one business makes a commercial transaction with another. This typically occurs when:\n\nA business is sourcing materials for their production process for output   (e.g., a food manufacturer purchasing salt), i.e.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Small_business">Small business</a></td>
      <td>Small businesses are  corporations, partnerships, or sole proprietorships which have fewer employees and/or less annual revenue than a regular-sized business or corporation. Businesses are defined as "small" in terms of being able to apply for government support and qualify for preferential tax policy varies depending on the country and industry.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_intelligence">Business intelligence</a></td>
      <td>Business intelligence (BI) comprises the strategies and technologies used by enterprises for the data analysis and management of business information. Common functions of business intelligence technologies include reporting, online analytical processing, analytics, dashboard development, data mining, process mining, complex event processing, business performance management, benchmarking, text mining, predictive analytics, and prescriptive analytics.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Data_acquisition">Data acquisition</a></td>
      <td>Data acquisition is the process of sampling signals that measure real world physical conditions and converting the resulting samples into digital numeric values that can be manipulated by a computer. Data acquisition systems, abbreviated by the initialisms DAS, DAQ, or DAU, typically convert analog waveforms into digital values for processing.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Right_to_Fair_Compensation_and_Transparency_in_Land_Acquisition,_Rehabilitation_and_Resettlement_Act,_2013">Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Act, 2013</a></td>
      <td>The Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Act, 2013 (also Land Acquisition Act, 2013 or LARR Act or RFCTLARR Act) is an Act of Indian Parliament that regulates land acquisition and lays down the procedure and rules for granting compensation, rehabilitation and resettlement to the affected persons in India. The Act has provisions to provide fair compensation to those whose land is taken away, brings transparency to the process of acquisition of land to set up factories or buildings, infrastructural projects and assures rehabilitation of those affected.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Integration_testing">Integration testing</a></td>
      <td>Integration testing (sometimes called integration and testing, abbreviated I&amp;T) is the phase in software testing in which individual software modules are combined and tested as a group. Integration testing is conducted to evaluate the compliance of a system or component with specified functional requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Integrator">Integrator</a></td>
      <td>An integrator in measurement and control applications is an element whose output signal is the time integral of its input signal. It accumulates the input quantity over a defined time to produce a representative output.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Continuous_integration">Continuous integration</a></td>
      <td>In software engineering, continuous integration (CI) is the practice of merging all developers' working copies to a shared mainline several times a day. Grady Booch first proposed the term CI in his 1991 method, although he did not advocate integrating several times a day.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Integration_by_parts">Integration by parts</a></td>
      <td>In calculus, and more generally in mathematical analysis, integration by parts or partial integration is a process that finds the integral of a product of functions in terms of the integral of the product of their derivative and antiderivative. It is frequently used to transform the antiderivative of a product of functions into an antiderivative for which a solution can be more easily found.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Dyslexia">Dyslexia</a></td>
      <td>Dyslexia, also known as reading disorder, is a disorder characterized by reading below the expected level for their age. Different people are affected to different degrees.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Degree_of_difficulty">Degree of difficulty</a></td>
      <td>Degree of difficulty (DD, sometimes called tariff or grade) is a concept used in several sports and other competitions to indicate the technical difficulty of a skill, performance, or course, often as a factor in scoring. Sports which incorporate a degree of difficulty in scoring include bouldering, cross-country skiing, diving, equestrianism, figure skating, freestyle skiing, gymnastics, rhythmic gymnastics, surfing, synchronized swimming and trampoline.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Dysphagia">Dysphagia</a></td>
      <td>Dysphoria (from Ancient Greek  δύσφορος (dúsphoros) 'grievous'; from  δυσ- (dus-) 'bad, difficult', and  φέρω (phérō) 'to bear') is a profound state of unease or dissatisfaction. It is the opposite of euphoria.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Ambiguous_grammar">Ambiguous grammar</a></td>
      <td>In computer science, an ambiguous grammar is a context-free grammar for which there exists a string that can have more than one leftmost derivation or parse tree, while an unambiguous grammar is a context-free grammar for which every valid string has a unique leftmost derivation or parse tree. Many languages admit both ambiguous and unambiguous grammars, while some languages admit only ambiguous grammars.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Coin_flipping">Coin flipping</a></td>
      <td>Coin debasement is the act of decreasing the amount of precious metal in a coin, while continuing to circulate it at face value. This was frequently done by governments in order to inflate the amount of currency in circulation; typically, some of the precious metal was replaced by a cheaper metal when the coin was minted.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Strength_of_materials">Strength of materials</a></td>
      <td>The field of strength of materials, also called mechanics of materials, typically refers to various methods of calculating the stresses and strains in structural members, such as beams, columns, and shafts. The methods employed to predict the response of a structure under loading and its susceptibility to various failure modes takes into account the properties of the materials such as its yield strength, ultimate strength, Young's modulus, and Poisson's ratio.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Successful_Pyrate">The Successful Pyrate</a></td>
      <td>The Successful Pyrate is a play by Charles Johnson, first performed 1712, published 1713, dealing with the life of the pirate Henry Avery. It opened at the Theatre Royal, Drury Lane on 7 November 1712 and ran for five evenings.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Kernes_Bloc_—_Successful_Kharkiv">Kernes Bloc — Successful Kharkiv</a></td>
      <td>Kernes Bloc — Successful Kharkiv (Ukrainian: Блок Кернеса — Успішний Харків, romanized: Blok Kernesa — Uspishnyy Kharkiv) is a political party of Ukraine, registered on April 12, 2016. The founder and first head of the political party was Hennadiy Kernes, who created it with the aim of participating in local elections in the Kharkiv Oblast, both in the City Council and in the Oblast Council.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/VMware_Infrastructure">VMware Infrastructure</a></td>
      <td>VMware Infrastructure is a collection of virtualization products from VMware (a division of Dell Technologies). Virtualization is an abstraction layer that decouples hardware from operating systems.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Chemical_castration">Chemical castration</a></td>
      <td>Chemical castration is castration via anaphrodisiac drugs, whether to reduce libido and sexual activity, to treat cancer, or otherwise. Unlike surgical castration, where the gonads are removed through an incision in the body, chemical castration does not remove organs, nor is it a form of sterilization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Technology">Technology</a></td>
      <td>Technology is the result of accumulated knowledge and application of skills, methods, and processes used in industrial production and scientific research. Technology is embedded in the operation of all machines, with or without detailed knowledge of their function, for the intended purpose of an organization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Technological_Society">The Technological Society</a></td>
      <td>The Technological Society is a book on the subject of technique by French philosopher, theologian and sociologist Jacques Ellul. Originally published in French in 1954, it was translated into English in 1964.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Visvesvaraya_Technological_University">Visvesvaraya Technological University</a></td>
      <td>Visvesvaraya Technological University (VTU), previously spelled Visveswaraiah Technological University, is a collegiate public state university in Belagavi, Karnataka established by the Government of Karnataka. All colleges in the State of Karnataka imparting education in Engineering or Technology, except those that have the consent of VTU and sanction of the Government, are required to be affiliated with Visvesvaraya Technological University, Belagavi.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>VENTIV HEALTH INC      Item 1A  Risk Factors           Risks Related to Our Business       We are a multi-faceted organization encompassing numerous segments, each     with its own <font color="blue">particular risks</font> and <font color="blue">uncertainties</font></td>
    </tr>
    <tr>
      <td>A wide range of factors     <font color="blue">could <font color="blue">materially</font> affect</font> our financial results and the performance of our     stock price</td>
    </tr>
    <tr>
      <td>The <font color="blue">most <font color="blue">significant</font> factors affecting</font> our <font color="blue">operations</font> include     the following:       Our  revenues  are  <font color="blue">dependent</font>  on  <font color="blue">expenditures</font>  by  companies  in the     <font color="blue">pharmaceutical</font> and <font color="blue">life <font color="blue">sciences industries</font></font>, and a variety of <font color="blue">factors could</font>     cause the <font color="blue">overall levels</font> of those <font color="blue">expenditures</font> to decline</td>
    </tr>
    <tr>
      <td>Our  revenues are highly <font color="blue">dependent</font> on <font color="blue">expenditures</font> by companies in the     <font color="blue">pharmaceutical</font>  and  other  life  <font color="blue">sciences industries</font> for <font color="blue">advertising</font>,     promotional, marketing and sales, recruiting, clinical staffing and support     and <font color="blue">compliance services</font></td>
    </tr>
    <tr>
      <td>Any decline in <font color="blue">aggregate demand</font> for these services     <font color="blue">could <font color="blue">negatively</font> affect</font> our business</td>
    </tr>
    <tr>
      <td>·     Advertising, promotional, marketing and sales <font color="blue">expenditures</font> by <font color="blue">pharmaceutical</font>     <font color="blue">manufacturers</font> have in the past been, and could in the future be, <font color="blue">negatively</font>     impacted by, among other things, governmental reform or <font color="blue">private market</font>     <font color="blue">initiatives intended</font> to reduce the cost of <font color="blue">pharmaceutical</font> products or by     governmental, medical association or <font color="blue">pharmaceutical</font> industry initiatives     designed to regulate the manner in which <font color="blue">pharmaceutical</font> <font color="blue">manufacturers</font>     promote their products</td>
    </tr>
    <tr>
      <td>·     <font color="blue">Consolidation </font>in the <font color="blue">pharmaceutical</font> industry <font color="blue">could <font color="blue">negatively</font> affect</font> certain     of our business units by reducing overall outsourced <font color="blue">expenditures</font>,     <font color="blue">particularly</font> in the sales, marketing and <font color="blue">staffing areas</font></td>
    </tr>
    <tr>
      <td>·     <font color="blue">Companies </font>may elect to perform <font color="blue">advertising</font>, promotional, marketing, sales,     compliance and other <font color="blue">services <font color="blue">internally</font> based on industry</font> and     company-specific factors such as the rate of <font color="blue">new product development</font> and FDA     approval of those products, number of <font color="blue">sales representatives employed</font>     <font color="blue">internally</font> in relation to demand for or the need to <font color="blue">promote new</font> and existing     products and <font color="blue">competition from</font> other suppliers</td>
    </tr>
    <tr>
      <td>·     <font color="blue">Companies </font>may elect to perform clinical tasks <font color="blue">internally</font> based on industry     and company-specific factors such as the rate of <font color="blue">new product development</font> and     FDA approval of those products, the number of <font color="blue">clinical professionals</font>     employed <font color="blue">internally</font> in relation to the demand for or the need to develop new     <font color="blue">drug candidates</font>, and <font color="blue">competition from</font> other suppliers</td>
    </tr>
    <tr>
      <td>Many  of  the contracts under which we <font color="blue">provide services</font> are subject to     <font color="blue">termination</font> on short notice, which may make our revenues less predictable</td>
    </tr>
    <tr>
      <td>We <font color="blue">provide services</font> to many of our <font color="blue">most <font color="blue">significant</font> clients <font color="blue">under contract</font>s</font>     that our <font color="blue">clients may cancel on</font> short notice (<font color="blue">generally</font> 10 to 120 days,     depending  on  the  specific  business unit)</td>
    </tr>
    <tr>
      <td>In addition, many of our     <font color="blue">pharmaceutical</font> sales contracts provide our <font color="blue">clients with</font> the <font color="blue">opportunity</font> to     <font color="blue">internalize</font>  the  sales  forces  <font color="blue">under contract</font></td>
    </tr>
    <tr>
      <td>Although we have been     successful in a number of cases in negotiating longer-term commitments and a     non-cancelable initial period for <font color="blue">pharmaceutical</font> sales contracts, we cannot     be assured that <font color="blue">clients will renew <font color="blue">relationship</font>s beyond</font> the <font color="blue">expiration date</font>     of <font color="blue">existing contracts</font> in any of our business units</td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot assure</font> you     that our <font color="blue">most <font color="blue">significant</font> clients will continue</font> to do business <font color="blue">with us over</font>     the long term</td>
    </tr>
    <tr>
      <td>If any of our <font color="blue"><font color="blue">significant</font> clients elect</font> to cancel, convert or     not renew their contracts, it could have a material adverse effect on our     <font color="blue">consolidated</font> results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We are in the process of <font color="blue">integrating several <font color="blue">significant</font> <font color="blue"><font color="blue">acquisition</font>s</font></font> and     expect to make future <font color="blue"><font color="blue">acquisition</font>s</font> which will involve additional risks                For  the past several years, a <font color="blue">significant</font> component of our growth     strategy has been the addition through <font color="blue"><font color="blue">acquisition</font>s</font> of <font color="blue">businesses</font> that     <font color="blue">complement</font> us <font color="blue">strategically</font> and are <font color="blue">accretive</font> to earnings</td>
    </tr>
    <tr>
      <td>We have and will     continue to seek to address the need to offer additional services through     <font color="blue"><font color="blue">acquisition</font>s</font> of other companies, including the personnel such <font color="blue"><font color="blue">acquisition</font>s</font>     may bring to us</td>
    </tr>
    <tr>
      <td>The <font color="blue">current market</font> for <font color="blue"><font color="blue">acquisition</font> targets</font> in our industry     is <font color="blue">extremely competitive</font>, and we may not be successful in continuing to     identify,  <font color="blue"><font color="blue">successfully</font> bid</font> for and complete <font color="blue"><font color="blue">acquisition</font>s</font> necessary to     achieve our operational and <font color="blue">financial goals</font></td>
    </tr>
    <tr>
      <td>Some of our <font color="blue"><font color="blue">acquisition</font>s</font>, including the <font color="blue">acquisition</font> of PRS, inChord and     Adheris, were completed <font color="blue">only recently</font></td>
    </tr>
    <tr>
      <td><font color="blue">Operational </font>and financial <font color="blue">integration</font>     of  the  acquired <font color="blue">businesses</font> is not yet complete and we may experience     <font color="blue">difficulties</font> in completing the <font color="blue">integration</font> processes</td>
    </tr>
    <tr>
      <td>Among other things, we     are <font color="blue">generally</font> required to document internal controls under Section 404 of     the Sarbanes-Oxley Act for each of our acquired business units by the end of     the first fiscal year following the year in which the <font color="blue">acquisition</font> occurs</td>
    </tr>
    <tr>
      <td>We     may  not  be successful in recognizing material <font color="blue">weaknesses</font> in internal     <font color="blue">controls over financial</font> reporting for our acquired <font color="blue">businesses</font> and may have     <font color="blue">difficulty remedying</font> any such material <font color="blue">weaknesses</font> on a <font color="blue">timely basis</font></td>
    </tr>
    <tr>
      <td><font color="blue">More     </font><font color="blue">generally</font>, we may experience <font color="blue">difficulties</font> in the <font color="blue">integration</font> of personnel     and <font color="blue">technologies across diverse</font> business platforms</td>
    </tr>
    <tr>
      <td><font color="blue"><font color="blue">Acquisitions </font> </font>involve  <font color="blue">numerous risks</font> in addition to <font color="blue">integration</font> risk,     including the following:           ·     diversion of <font color="blue">management</font>’s attention from normal daily <font color="blue">operations</font> of the     business;               ·     insufficient revenues to <font color="blue">offset increased expenses associated with</font>     <font color="blue"><font color="blue">acquisition</font>s</font>; and               ·     the <font color="blue">potential loss</font> of <font color="blue">key customers</font> or employees of the acquired companies</td>
    </tr>
    <tr>
      <td>Acquisitions, and related <font color="blue">acquisition</font> earnouts, may also cause us to deplete     our cash reserves and/or increase our leverage, and therefore increase the     financial risk of our capital structure; assume <font color="blue">liabilities</font> of the acquired     <font color="blue">businesses</font>; record goodwill and non-amortizable intangible assets that will     be subject to <font color="blue">impairment testing</font> and <font color="blue">potential periodic impairment charges</font>;     <font color="blue">incur amortization expenses</font> related to <font color="blue">certain intangible assets</font>; or become     subject to <font color="blue">litigation</font></td>
    </tr>
    <tr>
      <td>Mergers and <font color="blue"><font color="blue">acquisition</font>s</font> of new <font color="blue">businesses</font> are <font color="blue">inherently</font> risky, and no     assurance can be given that our previous or future <font color="blue"><font color="blue">acquisition</font>s</font> will be     successful  and will not <font color="blue">materially</font> and <font color="blue"><font color="blue">adversely</font> affect</font> our business,     operating  results,  or  financial  condition</td>
    </tr>
    <tr>
      <td><font color="blue">Failure  </font>to manage and     <font color="blue">successfully</font> integrate <font color="blue"><font color="blue">acquisition</font>s</font> we make could harm our operational and     <font color="blue">consolidated</font> financial results in a material way</td>
    </tr>
    <tr>
      <td>We may not be successful in managing our <font color="blue">infrastructure</font> and resources to     <font color="blue">support continued growth</font></td>
    </tr>
    <tr>
      <td>Our ability to <font color="blue">grow also depends</font> to a <font color="blue">significant</font> degree on our ability to     <font color="blue">successfully</font> leverage our existing <font color="blue">infrastructure</font> to perform services for     our clients, develop and <font color="blue">successfully</font> implement <font color="blue">new sales channels</font> for the     services we offer and to enhance and expand the range of services that we     can deliver to our customers</td>
    </tr>
    <tr>
      <td>Our <font color="blue">growth will also depend on</font> a number of     other factors, including our ability to       ·     maintain the <font color="blue">high quality</font> of the services we provide to our customers;       ·     increase our <font color="blue">penetration with existing customers</font>;       ·     recruit, motivate and retain <font color="blue">qualified personnel</font>;           ·     implement operational and <font color="blue">financial systems</font> and <font color="blue">additional <font color="blue">management</font></font>     resources to operate <font color="blue">efficiently</font> and <font color="blue"><font color="blue">effectively</font> regardless</font> of market     <font color="blue">conditions</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot assure</font> you that we will be able to manage or expand our <font color="blue">operations</font>     <font color="blue">effectively</font> to <font color="blue">address current</font> or <font color="blue">future demand</font> and market <font color="blue">conditions</font></td>
    </tr>
    <tr>
      <td>If we     are unable to manage our <font color="blue">infrastructure</font> and resources <font color="blue">effectively</font>, our     business, <font color="blue">consolidated</font> financial condition and <font color="blue">consolidated</font> results of     <font color="blue">operations</font> could be <font color="blue">materially</font> and <font color="blue"><font color="blue">adversely</font> affect</font>ed</td>
    </tr>
    <tr>
      <td>7       _________________________________________________________________       We are subject to a high degree of <font color="blue">government regulation</font></td>
    </tr>
    <tr>
      <td>We  are subject to a high degree of <font color="blue">government regulation</font></td>
    </tr>
    <tr>
      <td><font color="blue">Significant     </font>changes in these <font color="blue">regulations</font>, or our failure to comply with them, could     <font color="blue">impose additional costs on us</font> or otherwise <font color="blue">negatively</font> affect our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our  services  are  subject  to  <font color="blue">evolving industry standards</font> and rapid     <font color="blue">technological</font> changes</td>
    </tr>
    <tr>
      <td>The  markets  for  our  services are <font color="blue">characterized by rapidly</font> changing     technology, <font color="blue">evolving industry standards</font> and <font color="blue">frequent introduction</font> of new and     <font color="blue">enhanced services</font></td>
    </tr>
    <tr>
      <td>To succeed, we <font color="blue">must continue</font> to enhance our existing     services; introduce <font color="blue">new services</font> on a timely and cost-effective basis to     meet evolving customer <font color="blue">requirements</font>; integrate <font color="blue">new services</font> with existing     services;  achieve  <font color="blue">market acceptance</font> for <font color="blue">new services</font>; and respond to     <font color="blue">emerging industry standards</font> and other <font color="blue">technological</font> changes</td>
    </tr>
    <tr>
      <td>We may be <font color="blue"><font color="blue">adversely</font> affect</font>ed by customer concentration</td>
    </tr>
    <tr>
      <td>We have two customers, individually, that accounted for in excess of 10prca of     our <font color="blue">net revenues</font> for the year ended <font color="blue">December </font>31, 2005, and our largest     <font color="blue">customer during such year accounted</font> for 14prca of <font color="blue">net revenues</font></td>
    </tr>
    <tr>
      <td>If any large     customer <font color="blue">decreases</font> or terminates its <font color="blue">relationship</font> with us, our business,     results of <font color="blue">consolidated</font> <font color="blue">operations</font> or <font color="blue">consolidated</font> financial position could     be <font color="blue">materially</font> <font color="blue"><font color="blue">adversely</font> affect</font>ed</td>
    </tr>
    <tr>
      <td>We may lose or fail to attract and retain <font color="blue">key employees</font> and <font color="blue">management</font>     personnel</td>
    </tr>
    <tr>
      <td>Our <font color="blue">key managerial</font> and other employees are among our <font color="blue">most important assets</font></td>
    </tr>
    <tr>
      <td>An <font color="blue">important aspect</font> of our <font color="blue">competitiveness</font> is our ability to attract and     retain <font color="blue">key employees</font> and <font color="blue">management</font> personnel</td>
    </tr>
    <tr>
      <td><font color="blue">Compensation </font>for these key     employees and <font color="blue">management</font> personnel is an essential factor in attracting and     retaining them, and there can be no assurance that we will offer a level of     <font color="blue">compensation</font> sufficient to do so</td>
    </tr>
    <tr>
      <td>Equity-based <font color="blue">compensation</font>, including     <font color="blue">compensation</font> in the form of options and restricted stock, plays an important     role  in  our  <font color="blue">compensation</font>  of new and <font color="blue">existing employees</font></td>
    </tr>
    <tr>
      <td>Because of     <font color="blue">limitations</font> on the number of shares available for future grant under our     equity  incentive  plan,  we  may  be  unable to meet the <font color="blue">compensation</font>     <font color="blue">requirements</font> of our <font color="blue">key employees</font> and <font color="blue">management</font> personnel</td>
    </tr>
    <tr>
      <td>We <font color="blue">may incur liability</font> in connection with <font color="blue">litigation</font></td>
    </tr>
    <tr>
      <td>We are subject from time to time to claims made <font color="blue">by third parties</font> relating to     our business</td>
    </tr>
    <tr>
      <td>We do not believe that any claims that are <font color="blue">currently pending</font>     will  have  a  material adverse effect on us</td>
    </tr>
    <tr>
      <td><font color="blue">Litigation </font>is <font color="blue">inherently</font>     uncertain, however, and we <font color="blue">cannot assure</font> you that we will not <font color="blue">suffer such</font> an     effect as a consequence of any pending or future claims</td>
    </tr>
  </tbody>
</table>